• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The in vivo molecular weight and renal threshold of hydroxyethyl starch in the example of molar substituted HES70/0/5].

作者信息

Förster H, Lehmann G, Asskali F

机构信息

Institut für Experimentelle Anaesthesiologie, Johann Wolfgang Goethe Universität, Frankfurt.

出版信息

Anasthesiol Intensivmed Notfallmed Schmerzther. 2001 Jan;36(1):31-7. doi: 10.1055/s-2001-10238.

DOI:10.1055/s-2001-10238
PMID:11227306
Abstract

The intravascular changes of the in vivo molecular weight of HES 70/0.5 were investigated on healthy volunteers. A repeated daily infusion of 835 ml of 6% HES solution (50 g HES 70/0.5; Rheohes) during four hours on five consecutive days was performed. The analysis of the distribution of the molecular masses in serum and urine was performed by SEC-HPLC with MALLS/RI detection. The in vivo average molecular weight (Mw) of HES was found to be 58,000 Da at the end of the infusion. This was lower than the Mw of 66,000 Da as measured initially in the HES solution. In the time following the infusion Mw increased steadily up to 64,000 Da because of renal elimination of low molecular HES. However, in the morning before the start of the next infusion of HES, the average molecular weight Mw of HES was even higher up to 71,000 Da. In the first collected portion of urine (i.e. up to 8 h after beginning the infusion) the average molecular weight of HES was as low as 17,000 Da. During the next hours (i.e. in the second collection period lasting from 8 up to 24 h after start of the HES infusion) Mw of HES increased up to 28,000 Da. The top fraction of the first period showed molecular masses of 27,000 Da, in the second collection period top fraction of molecular masses measured 40,000 Da. According to the presented data it is concluded that the renal threshold for medium substituted HES is independent of the initial Mw and related primarily to the molar substitution of the HES used. This renal threshold for medium substituted HES is determined to be at 40,000 Da. The in vivo Mw of HES is variable and related to the sampling time and predicted predominantly by the molar substitution of the HES used. The in vivo Mw, therefore, is not suited for characterisation of HES.

摘要

相似文献

1
[The in vivo molecular weight and renal threshold of hydroxyethyl starch in the example of molar substituted HES70/0/5].
Anasthesiol Intensivmed Notfallmed Schmerzther. 2001 Jan;36(1):31-7. doi: 10.1055/s-2001-10238.
2
[The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].[健康志愿者重复输注后不同取代羟乙基淀粉(HES)的蓄积情况]
Anasthesiol Intensivmed Notfallmed Schmerzther. 1999 Sep;34(9):537-41. doi: 10.1055/s-1999-208.
3
Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.肝移植无肝期平衡盐基高分子量与盐基低分子量羟乙基淀粉溶液的凝血及生化效应
Anaesthesia. 2008 Mar;63(3):235-42. doi: 10.1111/j.1365-2044.2007.05345.x.
4
Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers.羟乙基淀粉的研究。第二部分:450/0.7、450/0.5、450/0.3、300/0.4、200/0.7、200/0.5、200/0.3和200/0.1型羟乙基淀粉在志愿者血清和尿液中输注后的分子量分布变化
Arzneimittelforschung. 1985;35(3):615-22.
5
Hydroxyethyl starch: the effect of molecular weight and degree of substitution on intravascular retention in vivo.
Anesth Analg. 2007 Sep;105(3):724-8. doi: 10.1213/01.ane.0000275198.84094.ad.
6
Impact of the C2/C6 ratio of high-molecular-weight hydroxyethyl starch on pharmacokinetics and blood coagulation in pigs.高分子量羟乙基淀粉的C2/C6比值对猪的药代动力学和血液凝固的影响
Anesthesiology. 2007 Sep;107(3):442-51. doi: 10.1097/01.anes.0000278879.76613.1c.
7
Coagulation disorders caused by hydroxyethyl starch.羟乙基淀粉引起的凝血障碍。
Thromb Haemost. 1997 Sep;78(3):974-83.
8
[Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].中分子羟乙基淀粉(HAS 200/0.5)的药代动力学
Infusionsther Klin Ernahr. 1980 Apr;7(2):96-102.
9
[Mathematical decription of the human intravascular elimination of HAS after repeated infusions].
Infusionsther Klin Ernahr. 1979 Apr;6(2):119-22.
10
Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
Arzneimittelforschung. 1997 Jan;47(1):18-22.

引用本文的文献

1
Changes in the degree of substitution of HES in vivo and their influence on methods for determining HES concentrations in plasma.体内 HES 取代度的变化及其对 HES 血浆浓度测定方法的影响。
PLoS One. 2023 Aug 22;18(8):e0290339. doi: 10.1371/journal.pone.0290339. eCollection 2023.
2
Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.分子量和取代度对羟乙基淀粉组织摄取的影响:临床研究的荟萃分析。
Clin Pharmacokinet. 2012 Apr 1;51(4):225-36. doi: 10.2165/11594700-000000000-00000.